The latest news from UKI2S and our portfolio companies
11th February 2021
In recognition of wide range of diverse innovators we work with and support, we are launching our ‘CEO Spotlight’ series. We will be chatting with a selection of our Portfolio Company CEO’s to learn more…
7th January 2021
Atelerix Ltd (Atelerix) announces the appointment of a new CEO as the company accelerates its growth programme.
17th December 2020
MIRICO Limited today announced that it has acquired Sedolabs Limited, an Oxford based provider of emissions analytics and visualisation software that helps emissions mitigation activities…
16th December 2020
The past year has highlighted the importance of scientific research in the clearest terms. Widespread public appreciation of how dependent we are on scientific excellence…
14th December 2020
Not every journey reaches its intended destination or takes the expected path en route to success. This is as true for commercialising scientific innovations as it is for any other business…
10th December 2020
Coventry, UK, 10th December 2020 / NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.
9th November 2020
At the UK Innovation and Science Seed Fund (UKI2S), we recognise the importance of supporting UK science across all sectors, including space technology.
2nd November 2020
Completing a UK/US merger can be a complicated and demanding undertaking at the best of times, let alone during a global pandemic. However, for UKI2S portfolio…
9th October 2020
R&D in the UK is thriving and extraordinary innovation can be found in all sectors, ranging from agritech to energy to pharma and beyond.
5th October 2020
Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, is pleased to announce that it has been named one of Scrip’s ’10 To Watch’ companies at Bio-Europe Digital.
30th September 2020
NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism.
10th September 2020
UK Innovation and Science Seed Fund (UKI2S) portfolio company, AgPlus Diagnostics, has been awarded two government grants to develop its COVID-19 assays, one for antigen detection and a serological assay to monitor immune response.
4th September 2020
Funding will be used to explore scalable methods of human cell preservation, transport, and re-presentation for clinical applications.
29th July 2020
The Smarter Food Company has raised £1m in funding to accelerate the development of food products with health benefits. Its first product will be a vegetable-based soup…
27th July 2020
In our latest guest blog, Antoine Espinet, Founder and CEO of MicrofluidX, shares his insights on how to build your team, tell your story and secure investors to manage a successful fund raise.
7th July 2020
Jim Naismith is Founder and Technical Director of GyreOx, a biotechnology company recently set up with investment from the UK Innovation and Science Seed Fund (UKI2S).
6th July 2020
Announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment…
22nd June 2020
The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S’s portfolio companies.
18th June 2020
In the current global climate, many people – and businesses – are struggling. On both a personal and professional level, these are the start of some challenging times…
15th June 2020
Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has been awarded £458,740 by Innovate UK…
5th June 2020
Perfectus Biomed Limited are excited to officially announce that our merger with Wyoming based laboratory, Extherid Biosciences, has now been completed.
2nd June 2020
Dr Carolyn Porter, CEO of CytoSeek, shares her experiences of running a company during the coronavirus pandemic and how the Company was able to keep running as usual through these challenging times.
28th May 2020
Atelerix is a biotechnology company providing an innovative solution for storing and transporting cells and tissues at room temperature.
28th April 2020
Tim Bestwick shares his insights on the opportunities and challenges for startups in the fusion energy industry of the future.
© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.